ARTICLE | Clinical News
Imagify perflubutane: SPA received
June 13, 2011 7:00 AM UTC
Acusphere received an SPA from FDA for a planned placebo-controlled Phase III trial to evaluate Imagify perflubutane in about 900 patients. The company did not disclose a timeline to begin the trial. ...